GWLLY yields 4.00% · JNJ yields 2.13%● Live data
📍 GWLLY pulled ahead of the other in Year 1
Combined, GWLLY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GWLLY + JNJ for your $10,000?
Great Wall Motor Company Limited researches and develops, manufactures, and sells automobiles, and automotive parts and components in China, Russia, South Africa, Australia, Saudi Arabia, Chile, and internationally. The company offers pick-up trucks, SUVs, sedans, and energy vehicles primarily under the Haval, WEY, ORA, Tank, and Great Wall Pickup brand names; and unmanned vehicles. It also provides auto molds; new energy vehicle transmission and electric drive system; repairs automobiles; and transports general goods, as well as daily cargo transportation services. In addition, the company offers investment and financing, buildings rental, logistics, business information consultation, scrap car recycling and dismantling, finance leasing, asset management, equity investment, technology information and development, trade consultation, international trade, financial guarantee, and after-sales services, as well as automotive technology research, development, and technical consultation services. Further, it processes, recycles, and sells waste and used materials; and sells lubricants. Additionally, the company engages in the wholesale and retail of car accessories. It also exports its products. Great Wall Motor Company Limited was formerly known as Baoding Great Wall Motor Company Limited and changed its name to Great Wall Motor Company Limited in May 2003. The company was founded in 1984 and is headquartered in Baoding, China. Great Wall Motor Company Limited is a subsidiary of Baoding Innovation Great Wall Asset Management Company Limited.
Full GWLLY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.